fig1
Figure 1. Flowchart of patient selection. A total of 532 patients with glioblastoma or brain metastasis treated between January 2020 and December 2023 were assessed for eligibility. After application of the exclusion criteria and assessment of video quality, 92 patients (46 with glioblastoma and 46 with brain metastasis) were included in the final study cohort.





